XML 92 R46.htm IDEA: XBRL DOCUMENT v3.20.1
LONG-TERM DEBT - Credit agreement (Details)
$ in Millions
Mar. 09, 2020
USD ($)
item
Jul. 29, 2019
USD ($)
Lender
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 17, 2019
USD ($)
Credit Agreement          
Debt instrument information          
Number of trenches | item 3        
Amended and Restated Credit Agreement          
Debt instrument information          
Debt Instrument, Face Amount $ 50.0        
Debt carrying amount     $ 35.0 $ 35.0  
Base interest rate 8.25%        
Additional interest (as a percent) 2.75%        
Debt instrument fee as a percent of the aggregate principal amount 1.00%        
Monthly payment as a percent of the aggregate principal amount beginning July 2023 1.50%        
Debt covenants          
Minimum aggregate cash balance to maintain after FDA approval $ 2.5        
Covenant quarterly payment required at beginning 10.5        
Covenant quarterly payment required at end $ 109.5        
Amended and Restated Credit Agreement | One-month LIBOR          
Debt instrument information          
Variable rate basis LIBOR        
Amended and Restated Credit Agreement, Trench 1 Loan          
Debt instrument information          
Debt Instrument, Face Amount   $ 15.0      
Amended and Restated Credit Agreement, Trench 2 Loan          
Debt instrument information          
Debt Instrument, Face Amount         $ 20.0
Amended and Restated Credit Agreement, Trench 3 Loan          
Debt instrument information          
Borrowing capacity     $ 15.0    
Shareholder Lender | Credit Agreement          
Debt instrument information          
Borrowing capacity   $ 50.0      
Number of lenders involved | Lender   2      
Registered offering per securities purchase agreement | Shareholder Lender          
Debt instrument information          
Number of lenders involved | Lender   1      
Gross proceeds from issuance of common stock   $ 14.0